PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration

被引:73
作者
Bell, Michelle C.
Meier, Shelby E.
Ingram, Alexandria L.
Abisambra, Jose F. [1 ,2 ]
机构
[1] Univ Kentucky, Sanders Brown Ctr Aging, 800 S Limestone St, Lexington, KY 40536 USA
[2] Univ Kentucky, Coll Med, Dept Physiol, 800 S Limestone St, Lexington, KY 40536 USA
关键词
eIF2; alpha; EIF2AK3; endoplasmic reticulum; neurodegeneration; PERK; tau; unfolded protein response; UNFOLDED PROTEIN RESPONSE; PROGRESSIVE SUPRANUCLEAR PALSY; CASPASE-CLEAVED TAU; AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY-CONTROL PROTEINS; NEURONAL CELL-DEATH; ER-STRESS; ALZHEIMERS-DISEASE; ALPHA-SYNUCLEIN; GRANULOVACUOLAR DEGENERATION;
D O I
10.2174/1567205013666151218145431
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The unfolded protein response (UPR) plays a vital role in maintaining cell homeostasis as a consequence of endoplasmic reticulum (ER) stress. However, prolonged UPR activity leads to cell death. This time-dependent dual functionality of the UPR represents the adaptive and cytotoxic pathways that result from ER stress. Chronic UPR activation in systemic and neurodegenerative diseases has been identified as an early sign of cellular dyshomeostasis. The Protein Kinase R-like ER Kinase (PERK) pathway is one of three major branches in the UPR, and it is the only one to modulate protein synthesis as an adaptive response. The specific identification of prolonged PERK activity has been correlated with the progression of disorders such as diabetes, Alzheimer's disease, and cancer, suggesting that PERK plays a role in the pathology of these disorders. For the first time, the term "PERK-opathies" is used to group these diseases in which PERK mediates detriment to the cell culminating in chronic disorders. This article reviews the literature documenting links between systemic disorders with the UPR, but with a specific emphasis on the PERK pathway. Then, articles reporting links between the UPR, and more specifically PERK, and neurodegenerative disorders are presented. Finally, a therapeutic perspective is discussed, where PERK interventions could be potential remedies for cellular dysfunction in chronic neurodegenerative disorders.
引用
收藏
页码:150 / 163
页数:14
相关论文
共 157 条
[1]  
Abdullah R., 2014, Experimental gerontology
[2]   Tau Accumulation Activates the Unfolded Protein Response by Impairing Endoplasmic Reticulum-Associated Degradation [J].
Abisambra, Jose F. ;
Jinwal, Umesh K. ;
Blair, Laura J. ;
O'Leary, John C., III ;
Li, Qingyou ;
Brady, Sarah ;
Wang, Li ;
Guidi, Chantal E. ;
Zhang, Bo ;
Nordhues, Bryce A. ;
Cockman, Matthew ;
Suntharalingham, Amirthaa ;
Li, Pengfei ;
Jin, Ying ;
Atkins, Christopher A. ;
Dickey, Chad A. .
JOURNAL OF NEUROSCIENCE, 2013, 33 (22) :9498-9507
[3]   DnaJA1 Antagonizes Constitutive Hsp70-Mediated Stabilization of Tau [J].
Abisambra, Jose F. ;
Jinwal, Umesh K. ;
Suntharalingam, Amirthaa ;
Arulselvam, Karthik ;
Brady, Sarah ;
Cockman, Matthew ;
Jin, Ying ;
Zhang, Bo ;
Dickey, Chad A. .
JOURNAL OF MOLECULAR BIOLOGY, 2012, 421 (4-5) :653-661
[4]   LDLR Expression and Localization Are Altered in Mouse and Human Cell Culture Models of Alzheimer's Disease [J].
Abisambra, Jose F. ;
Fiorelli, Tina ;
Padmanabhan, Jaya ;
Neame, Peter ;
Wefes, Inge ;
Potter, Huntington .
PLOS ONE, 2010, 5 (01)
[5]   ATF6 Is a Transcription Factor Specializing in the Regulation of Quality Control Proteins in the Endoplasmic Reticulum [J].
Adachi, Yusuke ;
Yamamoto, Keisuke ;
Okada, Tetsuya ;
Yoshida, Hiderou ;
Harada, Akihiro ;
Mori, Kazutoshi .
CELL STRUCTURE AND FUNCTION, 2008, 33 (01) :75-89
[6]  
Amato A. A., 2008, NEUROMUSCULAR DISORD
[7]   Endoplasmic reticulum stress and diabetes mellitus [J].
Araki, E ;
Oyadomari, S ;
Mori, M .
INTERNAL MEDICINE, 2003, 42 (01) :7-14
[8]   Characterization of a Novel PERK Kinase Inhibitor with Antitumor and Antiangiogenic Activity [J].
Atkins, Charity ;
Liu, Qi ;
Minthorn, Elisabeth ;
Zhang, Shu-Yun ;
Figueroa, David J. ;
Moss, Katherine ;
Stanley, Thomas B. ;
Sanders, Brent ;
Goetz, Aaron ;
Gaul, Nathan ;
Choudhry, Anthony E. ;
Alsaid, Hasan ;
Jucker, Beat M. ;
Axten, Jeffrey M. ;
Kumar, Rakesh .
CANCER RESEARCH, 2013, 73 (06) :1993-2002
[9]   Discovery of 7-Methyl-5-(1-{[3-(trifluoromethyl)phenyl]acetyl}-2,3-dihydro-1H-indol-5-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine (GSK2606414), a Potent and Selective First-in-Class Inhibitor of Protein Kinase R (PKR)-like Endoplasmic Reticulum Kinase (PERK) [J].
Axten, Jeffrey M. ;
Medina, Jesus R. ;
Feng, Yanhong ;
Shu, Arthur ;
Romeril, Stuart P. ;
Grant, Seth W. ;
Li, William Hoi Hong ;
Heerding, Dirk A. ;
Minthorn, Elisabeth ;
Mencken, Thomas ;
Atkins, Charity ;
Liu, Qi ;
Rabindran, Sridhar ;
Kumar, Rakesh ;
Hong, Xuan ;
Goetz, Aaron ;
Stanley, Thomas ;
Taylor, J. David ;
Sigethy, Scott D. ;
Tomberlin, Ginger H. ;
Hassell, Annie M. ;
Kahler, Kirsten M. ;
Shewchuk, Lisa M. ;
Gampe, Robert T. .
JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) :7193-7207
[10]   Translation Attenuation through elF2α Phosphorylation Prevents Oxidative Stress and Maintains the Differentiated State in β Cells [J].
Back, Sung Hoon ;
Scheuner, Donalyn ;
Han, Jaeseok ;
Song, Benbo ;
Ribick, Mark ;
Wang, Junying ;
Gildersleeve, Robert D. ;
Pennathur, Subramaniam ;
Kaufman, Randal J. .
CELL METABOLISM, 2009, 10 (01) :13-26